Remove 2014 Remove Cannabinoids Remove Clinical Trials Remove DEA
article thumbnail

CBD: Everything You Need to Know

CannaMD

In honor of National CBD Day, CannaMD wants to clear up some cannabinoid confusion once and for all. However, many of these products contain a number of other cannabinoids as well. To understand cannabinoids, we need to take a closer look at the endocannabinoid system. In 1970, the U.S.

CBD 99
article thumbnail

Cannabis Industry Leaders Speak With CLR on Current Delta 8 Issues In The Industry

Cannabis Law Report

We support the Hemp Roundtable’s statements on psychoactive hemp and that it should be regulated separately from hemp, CBD, CBG and other non-psychoactive or non-intoxicating cannabinoids. As a graduate student, he received the IPMI Richard Rubin Memorial Scholarship in 2014 for his research in precious metals.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

U.S. Funding Focuses on Marijuana’s Harms, Not Benefits

CannaMD

research scene is also dominated by research on the harmful effects of cannabis, but Canada has dedicated much more funding to positive cannabinoid research. Non-profit organizations like the Canadian Consortium for Investigation of Cannabinoids (CCIC) were also formed to do research. The DEA would then be the exclusive distributor.

DEA 105
article thumbnail

Guest Post: Is CBD Legal? Federal & State Laws [2019]

Cannabis Law Report

All cannabis plants contain cannabinoids, which are a group of similar compounds. The industrial hemp plant happens to contain large quantities of special cannabinoids known as cannabidiol or CBD for short. In 2014, Mississippi legalized CBD for epileptic patients. One variation of cannabis is called hemp.

article thumbnail

Report: “Key pharmacological differences between side effects of refined, pharmaceutical CBD formulations and whole plant extracts:”

Cannabis Law Report

International Cannabinoid Cancer Research Institute (Draft 5). This paper seeks to answer why refined cannabinoids have more side effects than the natural cannabis product, as well as the possible etiology of said adverse reactions. Also discussed are other attempts at affecting the cannabinoid system from a singular standpoint.

article thumbnail

Buzzes & Bummers: 2018 Was a Wild Ride in the World of Cannabis

SpeedWeed

In August, Constellation Brands (brewers of Corona beer) spent $4 billion to massively up their stake in Canopy Growth, which in 2014 became the first publicly traded cannabis company in North America, and now lists on both the New York Stock Exchange and the Toronto Stock Exchange.